Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03560141 · ClinicalTrials.gov registry record · NA

Clinical Performance of a Silicone Hydrogel Contact Lens Following One Night of Extended Wear

A NA study of Refractive Errors, sponsored by Alcon Research.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT03560141 is a NA study of Refractive Errors that has completed, run by Alcon Research. The registered enrollment target is 12 participants, below the 106-participant average among 14 other Refractive Errors trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03560141, a NA study of Refractive Errors, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The purpose of this clinical study is to evaluate the on-eye performance of an investigational soft contact lens compared to a commercially available soft contact lens following 1 night of extended wear.

Conditions Studied

Interventions

  • DEVICE LID011121 contact lens
  • DEVICE Comfilcon A contact lens

Study Locations (1)

Georgia

  • Alcon Investigative Site - Johns Creek

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2018-07-11
Est. Completion 2018-07-17
Phase NA

Sponsor

Alcon Research

275 total trials

What the Registry Record Tells You About NCT03560141

The ClinicalTrials.gov registry entry for NCT03560141 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 106-participant average among 14 other Refractive Errors trials with a reported enrollment target (89% lower). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Refractive Errors appearing as the primary indexed condition, and to 2 interventions - of which LID011121 contact lens is the first listed.

NCT03560141 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT03560141 about?

NCT03560141 is a clinical study titled "Clinical Performance of a Silicone Hydrogel Contact Lens Following One Night of Extended Wear". The purpose of this clinical study is to evaluate the on-eye performance of an investigational soft contact lens compared to a commercially available soft contact lens following 1 night of extended wear.

What is the current status of trial NCT03560141?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-07-11. Estimated completion is 2018-07-17.

What conditions does trial NCT03560141 study?

This clinical trial studies the following conditions: Refractive Errors.

What interventions are being tested in trial NCT03560141?

The interventions under investigation include: LID011121 contact lens (DEVICE), Comfilcon A contact lens (DEVICE).

Who is sponsoring clinical trial NCT03560141?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03560141 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Refractive Errors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.